In view of the role of the polymorphism in BER enzymes in colorectal carcinogenesis, we evaluated the influence of the APE1 Asp148Glu polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in normal and tumor samples from patients with colorectal cancer. Here, PARP1 is linked to neoplasm.